Type to search

AdBio Partners Welcomes Inserm Transfert As Investor in Second Fund – AFB Fund II | Pharmtech Focus
New Startup Aglaia Therapeutics Raises €4m in Seed Funding to Overcome Resistance in Oncology Targeted Therapies | Pharmtech Focus